HIV News and Research

RSS

Novel graphene oxide-based biosensor may speed up development of new drugs against HIV, cancer

Longing to find a cure for cancer, HIV and other yet incurable diseases, researchers have already tried out hundreds of drugs, each requiring preclinical and clinical testing with live subjects. How many chemical agents more to try? Moving at such rate, will we find the cure during our lifetime? One of the easiest ways to speed up the drug development process is to simply perform it outside of the living body (e.g., by watching the substances react with the smallest pieces of live tissue and thus quickly predicting the overall effect it will make to the body when inside).

23 Sep 2015

Protein-based modular system could help detect viral infection or kill cancer cells

MIT biological engineers have developed a modular system of proteins that can detect a particular DNA sequence in a cell and then trigger a specific response, such as cell death.

22 Sep 2015

Vaginal silicone ring may protect women against HIV, herpes virus

Researchers at University Jean Monnet of Saint-Etienne, France have succeeded in developing a vaginal silicone ring that delivers molecules that act on both HIV and herpes virus. This research is presented at the 55th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC/ICC).

21 Sep 2015

Results from phase 3 women-only HIV study show improved safety, efficacy of Stribild drug

Results from the first phase 3 HIV study to enroll only women show improved safety and efficacy of the drug Stribild over multi-pill antiretroviral drug regimens. The research was presented at ASM's 55th Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC/ICC).

21 Sep 2015

Mylan releases Fluvastatin Sodium Extended-release Tablets in the U.S.

Mylan N.V. today announced the U.S. launch of Fluvastatin Sodium Extended-release Tablets, 80 mg, which is the generic version of Novartis' Lescol XL Tablets.

18 Sep 2015

UC San Diego, TSRI form new consortium to map cells in space and time

Drawing on complementary strengths of two San Diego institutions, The Scripps Research Institute (TSRI) and the University of California, San Diego (UC San Diego) have formed a new consortium with a big mission: to map cells in space and time.

18 Sep 2015

Study shows fear and stigma are major factors that contribute to spread of AIDS, Ebola

Just weeks after Sierra Leone discharged its last patient, a new study reflects on the lessons learnt from the recent outbreak of Ebola, comparing it with that of AIDS in Africa in the early 1980s.

18 Sep 2015

Benitec Biopharma initiates new site for ongoing Phase 1/2a TT-034 trial for hepatitis C

Benitec Biopharma Limited, a clinical-stage biotechnology company developing innovative therapeutics based on its gene-silencing technology, DNA-directed RNA interference (ddRNAi), is pleased to announce it has initiated a new site for its ongoing Phase 1/2a TT-034 trial at the Methodist Health System Clinical Research Institute in Dallas, Texas.

16 Sep 2015

Study reports use of new psychoactive drugs in US nationally representative survey

In recent years, there has been an increase in emergence and use of a variety of new drugs, so-called "novel psychoactive substances" (NPS) in the US and worldwide.

16 Sep 2015

Study: Skin microbiome can influence outcomes of chancroid

For years, researchers have known that the human skin is home to a diverse community of microorganisms, collectively known as the skin microbiome. Now a new study has shown that individuals with a particular skin microbiome can effectively clear bacteria that cause chancroid, a sexually transmitted disease common in the developing world that has been linked to enhanced HIV transmission.

16 Sep 2015

Researchers discover new gene that could be a potential therapeutic target for muscle wasting

It is estimated that half of all cancer patients suffer from a muscle wasting syndrome called cachexia. Cancer cachexia impairs quality of life and response to therapy, which increases morbidity and mortality of cancer patients. Currently, there is no approved treatment for muscle wasting but a new study from the Research Institute of the McGill University Health Centre and University of Alberta could be a game changer for patients, improving both quality of life and longevity.

15 Sep 2015

A Day with HIV: A new initiative to tackle stigma, discrimination against HIV patients

On one day, Tuesday, September 22nd, Positively Aware and TPAN are inviting everyone, regardless of HIV status, to get in the picture and participate in A Day with HIV, the magazine's sixth annual anti-stigma photo campaign. On 9/22/2015 people across the world, whether HIV-positive or negative, will visually capture and share a moment of their day – A Day with HIV – to focus attention on what it means to live in a world with HIV.

14 Sep 2015

UN reports that more needs to be done so all children are born HIV and syphilis free in Asia-Pacific region

The Asia–Pacific region has made significant progress in efforts to eliminate HIV and syphilis, but thousands of mothers and children have yet to feel the benefits.

14 Sep 2015

UNITAID, EGPAF launch new initiative to scale up HIV diagnosis among newborns in African countries

UNITAID and the Elizabeth Glaser Pediatric AIDS Foundation today launched an initiative that will dramatically scale up HIV diagnosis among newborns in nine African countries. In partnership with ministries of health, this initiative will make "point-of-care" testing more widely available to HIV-exposed infants early in their lives, when they are most at risk of dying, and enable those diagnosed with the virus to be put on lifesaving treatment more quickly.

14 Sep 2015

NYUCN researchers study sexual transmission of HCV among HIV-positive MSM

While sexual contact is not the most efficient means of hepatitis C (HCV) transmission, there have been several reports of outbreaks of sexually transmitted HCV in HIV-positive men who have sex with men (MSM). HCV infections are more likely to become persistent and to lead to progressive liver disease in people who are HIV-infected, even if they are receiving HIV treatment. Factors underlying these infections in HIV-positive MSM are only partially understood.

14 Sep 2015

Caltech researchers find antibody that can detect, neutralize HIV viruses in infected patients

Proteins called broadly neutralizing antibodies (bNAbs) are a promising key to the prevention of infection by HIV, the virus that causes AIDS. bNAbs have been found in blood samples from some HIV patients whose immune systems can naturally control the infection.

14 Sep 2015

HIV News and Research

Novel graphene oxide-based biosensor may speed up development of new drugs against HIV, cancer

Protein-based modular system could help detect viral infection or kill cancer cells

Vaginal silicone ring may protect women against HIV, herpes virus

Results from phase 3 women-only HIV study show improved safety, efficacy of Stribild drug

Mylan releases Fluvastatin Sodium Extended-release Tablets in the U.S.

UC San Diego, TSRI form new consortium to map cells in space and time

Study shows fear and stigma are major factors that contribute to spread of AIDS, Ebola

Benitec Biopharma initiates new site for ongoing Phase 1/2a TT-034 trial for hepatitis C

Study reports use of new psychoactive drugs in US nationally representative survey

Study: Skin microbiome can influence outcomes of chancroid

Researchers discover new gene that could be a potential therapeutic target for muscle wasting

A Day with HIV: A new initiative to tackle stigma, discrimination against HIV patients

UN reports that more needs to be done so all children are born HIV and syphilis free in Asia-Pacific region

UNITAID, EGPAF launch new initiative to scale up HIV diagnosis among newborns in African countries

NYUCN researchers study sexual transmission of HCV among HIV-positive MSM

Caltech researchers find antibody that can detect, neutralize HIV viruses in infected patients

A growing number of deaths attributed to avoidable risk factors

High blood pressure, smoking, and poor dietary habits are greatest risk factors for death

Psychosis, hepatitis C infection are greatest risk factors for mortality in marginalized Vancouver residents

Nurse-trainer uses new approach to teach correct combination of HIV drugs to Angola's nurses

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Exploring the G:Box and for high-quality imaging

Latest News